Glucose/Diabetes Monitoring held a 32.36% share of the point-of-care diagnostics market in 2025, reflecting its entrenched role in routine disease management and frequent testing needs. its position is maintained through the practical reality that diabetes care depends on regular, rapid measurement across clinical and near-patient settings, making these products part of everyday care workflows rather than occasional diagnostic tools. This steady testing cadence supports consistent demand in the point-of-care diagnostics market and gives glucose monitoring a durable volume advantage over more episodic testing categories.

Infectious Disease Testing is emerging as the fastest-growing product area in the point-of-care diagnostics market because speed of diagnosis has become critical where treatment decisions and infection control measures must be made without delay. The segment is gaining momentum as care settings increasingly value rapid, decentralized testing that can support immediate clinical action and reduce dependence on central laboratory turnaround times. Compared with alternatives that are used mainly for ongoing chronic monitoring, infectious disease testing benefits from its expanding role in urgent assessment and quick decision-making across diverse patient encounter points.

End-use Segment Analysis: Clinics (Largest Segment) vs Home (Fastest-Growing Segment)

Clinics accounted for the largest share of the point-of-care diagnostics market in 2025, reinforced through their central role in delivering routine consultations, first-line assessment, and immediate test-based decisions during patient visits. Their leadership comes from the operational convenience of combining examination, diagnosis, and treatment planning in one setting, where rapid testing can be integrated directly into provider workflows. This makes clinics a consistent demand center in the point-of-care diagnostics market, especially for conditions that require quick interpretation by healthcare professionals.

Home is the fastest-growing end-use segment in the point-of-care diagnostics market as testing continues to move closer to the patient for convenience, continuity, and faster self-directed action. Its momentum is driven by the practical appeal of reducing visits to care facilities while enabling regular monitoring or early detection in a familiar setting. Relative to clinic-based use, home testing is advancing because it better aligns with growing demand for accessible, on-demand diagnostics that fit into daily life without requiring direct provider supervision for every test event.